IVIG Delays Onset in a Mouse Model of Gerstmann-Sträussler-Scheinker Disease

Molecular Neurobiology
H GuY Du

Abstract

Our previous studies showed that intravenous immunoglobulin (IVIG) contained anti-Aβ autoantibodies that might be able to treat Alzheimer's disease (AD). Recently, we identified and characterized naturally occurring autoantibodies against PrP from IVIG. Although autoantibodies in IVIG blocked PrP fibril formation and PrP neurotoxicity in vitro, it remained unknown whether IVIG could reduce amyloid plaque pathology in vivo and be used to effectively treat animals with prion diseases. In this study, we used Gerstmann-Sträussler-Scheinker (GSS)-Tg (PrP-A116V) transgenic mice to test IVIG efficacy since amyloid plaque formation played an important role in GSS pathogenesis. Here, we provided strong evidence that demonstrates how IVIG could significantly delay disease onset, elongate survival, and improve clinical phenotype in Tg (PrP-A116V) mice. Additionally, in treated animals, IVIG could markedly inhibit PrP amyloid plaque formation and attenuate neuronal apoptosis at the age of 120 days in mice. Our results indicate that IVIG may be a potential, effective therapeutic treatment for GSS and other prion diseases.

References

Jun 14, 1991·Science·S B Prusiner
Apr 1, 1996·Brain Pathology·B GhettiF Tagliavini
Jun 28, 2000·Microscopy Research and Technique·O BugianiB Ghetti
Sep 5, 2001·Nature Medicine·F L HeppnerA Aguzzi
Jan 17, 2002·Proceedings of the National Academy of Sciences of the United States of America·Marco PrinzAdriano Aguzzi
Jan 31, 2004·Science·Laura SolforosiR Anthony Williamson
Sep 3, 2004·Nature Reviews. Immunology·Adriano Aguzzi, Christina J Sigurdson
Sep 21, 2004·Journal of Neurology, Neurosurgery, and Psychiatry·R C DodelW H Oertel
Oct 13, 2005·American Journal of Physiology. Heart and Circulatory Physiology·Jiangning TanYansheng Du
Sep 19, 2006·Nature Reviews. Microbiology·Adriano Aguzzi, Mathias Heikenwalder
Mar 7, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Bridget R Glaysher, Neil A Mabbott
Jul 10, 2007·The FEBS Journal·Thomas Wisniewski, Einar M Sigurdsson
Aug 14, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Wenbin YangJames A Mastrianni
Apr 15, 2011·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Richard DodelMichael Bacher
Mar 1, 2012·The Journal of Biological Chemistry·Xing WeiYansheng Du
Sep 8, 2012·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Constanza J CortesJames A Mastrianni
Apr 25, 2014·Journal of Clinical Immunology·Norman Relkin

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic
fluorescence microscopy

Software Mentioned

ImageJ

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Alzheimer's Disease: Animal Models

Alzheimer's disease is a neurodegenerative disease which can be studied using various experimental systems. This feed focuses on animal models used for Alzheimer's disease research.

Related Papers

Advances in Experimental Medicine and Biology
Jan-Philipp Bach, Richard Dodel
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
Constanza J CortesJames A Mastrianni
Nihon rinsho. Japanese journal of clinical medicine
Hiroyuki Tomimitsu, Hidehiro Mizusawa
British Medical Bulletin
C WeissmannA Aguzzi
© 2022 Meta ULC. All rights reserved